July 20, 2017 / 8:29 AM / a month ago

BRIEF-Spain's Oryzon sees no impact of Roche decision on finances

July 20 (Reuters) - Spain's Oryzon CEO Carlos Buesa:

* Says the decision by Roche to drop cancer drug will not have a short-, medium-term impact on Oryzon finances

* Says: "The company's capacity to continue developing its business is stable from the financial point of view." Source text for Eikon: Further company coverage: (Reporting by Madrid Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below